Workflow
医疗保健设备
icon
Search documents
年内调研近万次!外资巨头盯上这些标的
2025年以来,近800家外资机构合计调研A股上市公司近万次。其中,Point 72资产管理公司以263次调 研位居榜首;高盛、美银证券等国际大行的调研次数也均超过百次。从调研方向来看,科技和医药是外 资机构最为关注的两大赛道。 年内外资调研A股近万次 Wind数据显示,截至12月26日,今年以来共有798家外资机构现身A股上市公司调研名单,合计调研 9308次。 具体来看,被称为"华尔街最疯狂赚钱机器"的Point 72资产管理公司今年以来调研A股上市公司263次, 排名首位。在2023和2024年,Point 72资产管理公司全年分别调研A股上市公司255次、259次,均为当 年外资调研榜第一位,堪称"A股调研劳模"。此外,高盛、美银证券、花旗环球等机构今年以来的调研 次数均超过100次。 | 혼득 | | | | | | --- | --- | --- | --- | --- | | | 机构名称 | | ਤੇਵਿਜ਼ | J 调研总次数 | | 1 | Point72 Asset Management, L.P. | => | 外资机构 | 263 | | 2 | 高盛(亚洲)证券有限公司 | 三> ...
四季度以来私募调研聚焦电子元件等领域
Zheng Quan Ri Bao· 2025-12-04 16:15
Group 1 - The fourth quarter is a critical period for private equity funds to realize performance and capture investment opportunities for the coming year, with research becoming a primary method for exploring new opportunities [1] - As of December 4, a total of 2,280 private equity institutions conducted 13,000 research sessions in the fourth quarter, with sectors like electronic components, medical devices, and integrated circuits being the most popular [1] - Private equity firms are optimistic about the A-share market in 2026 and are actively adjusting their portfolios through research to ensure more rational asset allocation and maximize product returns [2][3] Group 2 - Leading private equity firms are actively conducting research, with several top firms ranking high in the number of sessions, including Guangdong Zhengyuan, Hongyun, and Shanghai Gao Yi, among others [2] - The active research by private equity firms signals a positive outlook on the A-share market and a focus on understanding industry developments and verifying company operations to achieve higher returns [2] - The demand for deep research and precise stock selection is increasing as the market shifts towards performance realization, particularly in the technology sector [3] Group 3 - Technology stocks, particularly in sectors like electronic components, medical devices, and integrated circuits, are favored by private equity firms, with companies like Luxshare Precision and Aibo Medical being researched over 100 times [3][4] - The electronic components sector has seen strong upward momentum this year, benefiting from multiple favorable factors such as AI hardware, semiconductor domestic substitution, and automotive electronics [4] - The focus on sectors with growth potential and profit certainty is expected to help private equity funds achieve excess returns, aligning with their criteria for asset selection [4]
外资机构密集调研,聚焦两大赛道
Group 1 - Foreign institutions have conducted a total of 9,084 investigations into A-share listed companies this year, indicating a positive outlook on Chinese assets [1][4] - Point72 Asset Management leads with 255 investigations, followed by Goldman Sachs with 235, and other notable firms like IGWT Investment and Neuberger Berman also showing significant activity [2][3] - The focus of foreign investigations is primarily on technology innovation and high-end manufacturing, with companies like Huichuan Technology, Mindray Medical, and Optoelectronics attracting the most attention [2][3] Group 2 - The increase in foreign investigations is translating into actual capital allocation, with northbound funds holding A-shares increasing by over 340 billion yuan this year [4] - The proportion of Chinese stocks held by the top 40 global investment institutions has risen to 1.1%, the highest level since the first quarter of 2023 [4] - Foreign institutions are preparing for next year's investments, particularly in technology stocks, which are seen as undervalued and supported by national policies and industry ecosystems [5][6]
私募最新调研路径曝光:中小私募调研‘广撒网’,多家百亿私募聚焦硬科技
Feng Huang Wang· 2025-11-23 13:42
Core Insights - The private equity research activity has shifted, with non-billion private equity firms dominating the top ten rankings, leaving only Gao Yi Asset as the sole billion-level firm [1][2] - Shangcheng Asset has emerged as a leader in research activity, conducting 228 research sessions and covering 219 stocks, making it the only firm to exceed 200 in both categories [1][2] - The increase in research activity among smaller private equity firms does not indicate a lack of engagement from billion-level firms, but rather reflects a strategic differentiation in the current market environment [1][7] Research Activity Rankings - As of November 23, non-billion private equity firms occupy nine out of the top ten spots in research activity, with Gao Yi Asset being the only billion-level firm [2][4] - Shangcheng Asset leads both the total number of research sessions and the number of stocks researched, followed by Zhengyuan Investment with 168 sessions and 158 stocks [2][3] Industry Focus - Billion-level private equity firms are concentrating on hard technology sectors, with notable interest from Gao Yi Asset in Hikvision and multiple firms jointly researching Luxshare Precision [1][7] - Shangcheng Asset's research has predominantly focused on industries such as medical devices, electronic components, and industrial machinery, with a significant number of stocks from the Shenzhen market [6][7] Notable Research Sessions - Shangcheng Asset has conducted the most research on Rongbai Technology, with three sessions, highlighting its position as a leading supplier of lithium battery materials [5][6] - Other billion-level firms like Zhongyang Investment and Hesheng Huiyi have shown interest in various sectors, including integrated circuits and medical devices, with multiple stocks being researched more than twice [7][8]
成长型标的成公募机构四季度以来调研重点
Zheng Quan Ri Bao· 2025-11-18 16:17
Group 1 - Public institutions have increased their research efforts significantly in Q4, with a total of 11,166 research activities conducted, representing a 47.78% increase compared to the same period last year [1] - The focus of research has shifted towards growth-oriented stocks in the Sci-Tech Innovation Board and the ChiNext market, which have become the primary targets for public institutions [3] - Major public institutions, including top and mid-sized firms, have maintained a high frequency of research activities, with 40 institutions conducting over 100 research sessions each in Q4 [1] Group 2 - Changjin Hexin Fund led the research activities with 427 sessions, focusing on industries such as industrial machinery, electronic components, and healthcare equipment [2] - Ping An Fund and Huaxia Fund followed with 256 and 231 research sessions respectively, with a similar focus on industrial machinery and electronic components [2] - The overall performance of companies in the Sci-Tech Innovation Board and ChiNext has improved significantly, making them attractive options for institutional investment in high-growth assets [3] Group 3 - The investment community is optimistic about the value of growth assets amid market fluctuations and the differentiation of AI-themed investments [4] - Long-term reforms are expected to enhance the investability of the Chinese market, attracting long-term capital and improving the market's ability to handle risks [4] - Emerging technologies are viewed as a key investment theme, with policies supporting technological innovation likely to translate into actual company performance in the coming years [4]
心动中国资产:四季度外资调研超千次,股票持仓升至1.1%
Group 1 - Foreign institutional investors have increased their holdings in Chinese stocks, with the allocation rising from -1.6% to -1.3% in Q3 2025, marking the highest level since Q1 2023 at 1.1% for the top 40 global investment institutions [1][3] - The sectors with the most significant increases in foreign investment include healthcare, insurance, energy, materials, and the internet, while automotive and technology sectors saw reductions [2][3] - The trend of foreign capital inflow into Chinese assets remains strong, with southbound capital inflows reaching $56 billion, maintaining record levels from Q1 2025, particularly in consumer discretionary, financials, and healthcare [4] Group 2 - A significant number of foreign institutions have conducted research on A-share companies, with nearly 1,300 investigations from October 1 to November 14, led by Goldman Sachs, Citigroup, and Morgan Stanley [2][6] - The most researched companies include Huaming Equipment, Optoelectronics, and United Imaging, indicating a strong interest in sectors like electrical components, electronic devices, and healthcare equipment [6] - Foreign investors are optimistic about opportunities in AI, engineering machinery, non-ferrous metals, and the advantages of Chinese manufacturing, suggesting a potential for market recovery and growth [7][8] Group 3 - The outlook for foreign capital inflow into Chinese assets is positive, with expectations of continued liquidity support from the Federal Reserve's policies and a growing attractiveness of A-shares in the global market [9]
心动中国资产!四季度外资调研超千次,股票持仓升至1.1%
Group 1: Foreign Investment Trends - Foreign institutional investors have increased their holdings in Chinese stocks, with the allocation rising from -1.6% to -1.3% in Q3 2025, marking the highest level since Q1 2023 at 1.1% for the top 40 global investment institutions [1][2] - The sectors with the most significant increases in foreign investment include healthcare, insurance, energy, materials, and the internet, while automotive and technology sectors saw reductions [2][3] Group 2: A-Share Market Research - From October 1 to November 14, foreign institutions conducted nearly 1300 research visits to A-share listed companies, with Goldman Sachs, Citigroup, and Morgan Stanley leading in the number of visits [1][5] - The most researched companies included Huaming Equipment, Optoelectronics, and United Imaging, indicating strong interest in sectors like electrical components, medical equipment, and industrial machinery [5] Group 3: Investment Focus Areas - Foreign institutions are optimistic about opportunities in AI, engineering machinery, non-ferrous metals, and the advantages of Chinese manufacturing, with a belief that the overall valuation of the A-share market remains reasonable [6][7] - The shift in investor sentiment reflects a growing recognition of the resilience and advantages of the manufacturing sector amid the transition from old to new economic drivers [7] Group 4: Future Outlook - There is an expectation that foreign capital inflow into Chinese assets will continue, supported by anticipated monetary easing from the Federal Reserve and a favorable environment for A-shares in the context of global capital rebalancing [8]
加仓!外资盯上这些股票,高盛:上调
Zheng Quan Shi Bao· 2025-11-06 14:08
Group 1 - Foreign institutions have conducted research on 309 A-share listed companies since October, focusing on high-growth industries such as artificial intelligence, industrial automation, new energy, semiconductors, and consumer electronics [1][3] - As of the end of Q3 this year, the market value of A-shares held by QFII institutions reached 150.4 billion yuan, an increase of over 33 billion yuan compared to the end of 2024, representing a growth rate of 28.4% [1][10] - Notable companies receiving significant foreign interest include Huaming Equipment, United Imaging Healthcare, Lens Technology, and Luxshare Precision, primarily in high-growth sectors [6][7] Group 2 - Goldman Sachs has raised its forecasts for China's export growth and actual GDP growth, indicating a positive outlook for the "14th Five-Year Plan" period [12][14] - The focus of foreign institutions is on the development of a strong domestic market and enhancing the competitiveness of advanced manufacturing, which is expected to positively impact A-shares [13][14] - The research interest from foreign institutions includes a variety of sectors, with a notable emphasis on companies involved in AI, industrial automation, new energy, and semiconductors [5][6]
加仓!外资,盯上这些股票!高盛:上调!
券商中国· 2025-11-06 12:35
Core Viewpoint - Foreign investment in A-shares is increasing, with significant focus on high-growth sectors such as artificial intelligence, industrial automation, new energy, semiconductors, and consumer electronics [1][2][9]. Group 1: Foreign Investment Trends - As of the end of Q3 this year, the market value of A-shares held by QFII institutions reached 150.4 billion yuan, an increase of over 33 billion yuan compared to the end of 2024, representing a growth rate of 28.4% [2][7]. - In Q3, QFII entered the top ten shareholders of 687 A-share companies and increased holdings in 141 companies [8]. Group 2: Company Research Focus - Since October, foreign institutions have conducted research on 309 A-share companies, primarily in industries such as industrial machinery, electrical equipment, electronic components, and healthcare [3][6]. - Notable companies receiving significant foreign interest include Huaming Equipment, United Imaging, Lens Technology, and Luxshare Precision, with many being in high-growth sectors [5][6]. Group 3: Economic Outlook and Predictions - Goldman Sachs has raised its forecasts for China's export growth and actual GDP growth, indicating a positive outlook for the "14th Five-Year Plan" period [9][11]. - The firm expects China's export volume to grow by 5% to 6% annually over the next few years, contributing to overall economic expansion [11].
外资10月以来密集调研A股 覆盖309家公司 重视“含科”量
Zheng Quan Shi Bao· 2025-11-04 17:48
Group 1: Foreign Investment Focus - Since October, foreign institutions have conducted research on 309 A-share listed companies, primarily focusing on high-growth industries such as artificial intelligence, industrial automation, new energy, semiconductors, and consumer electronics [1][3] - Notably, 35 companies received attention from more than 10 foreign institutions, indicating a strong interest in companies like Huaming Equipment, United Imaging Healthcare, Lens Technology, and others [3] - Major foreign institutions involved in the research include Goldman Sachs, UBS, and Morgan Stanley, with Goldman Sachs alone researching over 50 A-share companies since October [5][6] Group 2: Company-Specific Insights - Huaming Equipment was the most researched company, with 82 foreign institutions focusing on its Q3 performance and future export orders [3][4] - United Imaging Healthcare attracted 71 foreign institutions, which were particularly interested in its performance in overseas markets and project deliveries [4] - Other companies like Lixun Precision, Han's Laser, and Jereh Group also received significant attention, reflecting a trend towards sectors like industrial machinery and medical equipment [1][3] Group 3: Economic Outlook and Policy Implications - Foreign institutions are optimistic about China's "14th Five-Year Plan," with Goldman Sachs raising its forecasts for China's export growth and GDP growth [2][6] - The focus on building a robust domestic market and enhancing advanced manufacturing capabilities is expected to positively impact A-shares, particularly in sectors related to self-sufficiency and emerging industries [6][7] - Goldman Sachs predicts that China's export volume will grow by 5% to 6% annually over the next few years, contributing to overall economic expansion [7]